Focus on scientific research · Based on practice

PRODUCTS

Is a modern pharmaceutical enterprises, mainly engaged in the treatment of diabetes, cardiovascular and cerebrovascular, liver disease, antiviral drugs and other research and development, production and sales.The company covers

Activating blood circulation and removing blood stasis, promoting the unification of blood vessels. Used for chest paralysis caused by blockage of blood vessels, symptoms of chest tightness and breathlessness, tingling in the precordial region, palpitation and forgetfulness, dizziness and tinnitus; coronary heart disease, angina pectoris, hyperlipidemia, and cerebral arterial insufficiency of blood supply see the above symptoms.

In patients with type 2 diabetes mellitus (non-insulin-dependent diabetes mellitus, NIDDM), pioglitazone hydrochloride may be used in combination with dietary control and physical activity to improve and control blood glucose.

Approval Number: State Drug License H20070229 Dosage Form: Tablet Specification: 15mg (in C19H20N2O3S). Manufacturer: Yantai Zhengfang Pharmaceutical Co., Ltd Address: No.16, Qinhuaihe Road, Yantai Economic and Technological Development Zone Product Category: Chemical Drugs Approval Date: 2012-11-01 Drug Code: 86904250000011 Execution Standard: The Second Supplement to Chinese Pharmacopoeia, 2010 Edition

Approval Number: State Drug License H20070229 Dosage Form: Tablet Specification: 15mg (in C19H20N2O3S). Manufacturer: Yantai Zhengfang Pharmaceutical Co., Ltd Address: No.16, Qinhuaihe Road, Yantai Economic and Technological Development Zone Product Category: Chemical Drugs Approval Date: 2012-11-01 Drug Code: 86904250000011 Execution Standard: The Second Supplement to Chinese Pharmacopoeia, 2010 Edition

Approval Number: State Drug License H20070229 Dosage Form: Tablet Specification: 15mg (in C19H20N2O3S). Manufacturer: Yantai Zhengfang Pharmaceutical Co., Ltd Address: No.16, Qinhuaihe Road, Yantai Economic and Technological Development Zone Product Category: Chemical Drugs Approval Date: 2012-11-01 Drug Code: 86904250000011 Execution Standard: The Second Supplement to Chinese Pharmacopoeia, 2010 Edition

Functions: Promoting blood circulation, removing blood stasis, and promoting blood circulation. It is used for chest paralysis caused by blood obstruction, which is characterized by chest tightness, tingling in the precordial region, palpitation, forgetfulness, dizziness and tinnitus; coronary heart disease, angina pectoris, hyperlipidemia, and insufficient blood supply to the cerebral arteries with the above symptoms. Product characteristics: 1, coronary heart disease, angina pectoris, hyperlipidemia, a new type of rapid-acting drugs; 2, pure traditional Chinese medicine single-prescription preparation, cardiovascular and cerebrovascular diseases synergistic treatment; 3, a new type of rapid-acting drug preparations, high bioavailability; 4, disintegrate rapidly, dispersed uniformly, fast onset of action.

Functions: Soothing the liver and strengthening the spleen, clearing heat and inducing dampness. It is used for hepatitis B surface antigen positive people who belong to the liver and spleen deficiency, heat and toxin are more abundant. Product characteristics: 1, for chronic hepatitis B surface antigen-positive people is especially obvious; 2, in the improvement of physical symptoms and self-conscious symptoms of the effect is ideal; 3, regulating the body's immune function, can quickly reduce the content of glutamic acid transaminase and glutamic acid transaminase; 4, according to the course of treatment after taking the drug, the hepatitis B virus carriers markers HbeAg and HbsAg to turn negative rate is high; 5, the recurrence rate is low, no toxic side effects.

Functions: Soothing the liver and strengthening the spleen, clearing heat and inducing dampness. It is used for hepatitis B surface antigen positive people who belong to the liver and spleen deficiency, heat and toxin are more abundant. Product characteristics: 1, for chronic hepatitis B surface antigen-positive people is especially obvious; 2, in the improvement of physical symptoms and self-conscious symptoms of the effect is ideal; 3, regulating the body's immune function, can quickly reduce the content of glutamic acid transaminase and glutamic acid transaminase; 4, according to the course of treatment after taking the drug, the hepatitis B virus carriers markers HbeAg and HbsAg to turn negative rate is high; 5, the recurrence rate is low, no toxic side effects.

Improvement of postprandial hyperglycemia in patients with type 2 diabetes mellitus (limited to patients who do not have effective glycemic control with diet and exercise therapy or those who do not have effective glycemic control with the addition of alpha-glucosidase inhibitors to diet and exercise therapy).

Exclusive national dosage form Fifteen provincial medical insurance Miglinide calcium capsules new generation of meal-time blood glucose regulator Glargine analogs are new structure of oral rapid-acting postprandial hypoglycemic drugs. Miglinide is the third new benzoic acid derivative hypoglycemic drug after Repaglinide and Naglinide, and is the latest generation of non-sulfonylurea insulin secretion promoter. It is the latest generation of non-sulfonylurea insulinotropic agent. It is known as "meal-time blood glucose regulator". Product Description [Approval Number] H20153263 [Approval Date] November 12, 2015 [Indications] Improve hyperglycemia in patients with type 2 diabetes mellitus [Usage and Dosage] Oral intake within 5 minutes before meals. Usually adults take 1 capsule each time, 3 times a day. Dosage can be adjusted according to the patient's therapeutic effect as appropriate. 【Specifications】10mg/capsule(based on Miglinide calcium)【Packaging】Aluminum plastic packaging, 10mg/capsule, 12 capsules/box; 24 capsules/box. Clinical features: 1, faster onset of action, shorter duration of action; 2, shorter duration of action, significantly reduce blood glucose and HbA1c levels; 3, high receptor selectivity, protection of pancreatic islet cells; 4, flexibility of administration, known as the "extracorporeal pancreas"; 5, first-line treatment for patients with early and mild diabetes mellitus; 6, high safety, good tolerance, long-term use. It can be used for a long time.

This product is a health food made of Pueraria Mirifica, Astragalus, Salvia Miltiorrhiza, Chromium Picolinate and Starch as the main raw materials, which has been proved by animal and human trial food function test to have the health function of assisting in lowering blood sugar.

Mainly engaged in the development, production and sales of drugs for the treatment of diabetes, cardiovascular and cerebrovascular diseases, liver diseases, antiviral drugs, etc.

< 12 >